Funding round for OGeS
Ambitious drug developer Oxford Genome Sciences (OGeS) has secured private equity funding of an undisclosed sum from a syndicate of investors. The funding round was led by Catapult Growth Fund and included South East Growth Fund and Oxford Capital Partners.
News